Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Spero Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
SPRO
Nasdaq
8731
https://sperotherapeutics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Spero Therapeutics Inc
14 Cheap Penny Stocks to Buy According to Analysts
- Apr 16th, 2024 3:52 pm
Spero Therapeutics, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
- Mar 17th, 2024 1:01 pm
Spero Therapeutics, Inc. (NASDAQ:SPRO) Q4 2023 Earnings Call Transcript
- Mar 15th, 2024 4:51 pm
Spero Therapeutics, Inc.'s (NASDAQ:SPRO) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
- Mar 15th, 2024 10:49 am
Q4 2023 Spero Therapeutics Inc Earnings Call
- Mar 14th, 2024 10:33 am
Spero Therapeutics, Inc. (SPRO) Q4 Earnings and Revenues Top Estimates
- Mar 13th, 2024 9:10 pm
Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update
- Mar 13th, 2024 8:01 pm
Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024
- Mar 6th, 2024 1:05 pm
Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections
- Feb 28th, 2024 1:05 pm
Spero Therapeutics to Present at Cowen’s 44th Annual Healthcare Conference
- Feb 26th, 2024 1:05 pm
Spero Therapeutics Inc CEO Sath Shukla Sells 75,994 Shares
- Feb 6th, 2024 4:27 am
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Jan 31st, 2024 9:05 pm
15 Cash-Rich Penny Stocks Hedge Funds Are Buying
- Jan 29th, 2024 9:07 am
11 Hyper-Growth Stocks Billionaires Are Loading Up On
- Jan 25th, 2024 9:40 am
Spero Therapeutics, Inc. (NASDAQ:SPRO): Are Analysts Optimistic?
- Jan 19th, 2024 1:20 pm
Spero Therapeutics Provides Corporate Update and 2024 Outlook
- Jan 5th, 2024 1:05 pm
Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract Infections
- Jan 2nd, 2024 1:05 pm
Spero Therapeutics, Inc. (NASDAQ:SPRO) Q3 2023 Earnings Call Transcript
- Nov 14th, 2023 2:02 pm
Spero Therapeutics Announces Third Quarter 2023 Operating Results and Provides a Business Update
- Nov 13th, 2023 9:05 pm
Spero Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results on Monday, November 13, 2023
- Nov 6th, 2023 1:05 pm
Scroll